GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
In contrast, in the liraglutide-treated group, the mean daily HR increased significantly from baseline at all times (66.5 10.2 to 79.7 10.5 bpm
Lecithins in processed food have been estimated to increase the daily consumption of phosphatidylcholine by about 1.5 mg/kg of body weight for adults (32)
Adenosylcobalamin injection, a specific type of Vitamin B12 supplementation, offer a bioactive form of B12 crucial for energy metabolism, nerve function, and cellular health when administered directly into the body, supporting overall vitality
Global Burden of Polycystic Ovary Syndrome: Socioeconomic Disparities, Reproductive Impacts, and Projections to 2050
How Melanotan Works and Why Regulators Rejected It Tanning is actually a defense mechanism